Related Experiment Video
Updated: Feb 26, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality
S Percy Ivy1, Johann de Bono2, Elise C Kohn1
1Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 9609 Medical Center Drive, Room 5W458, MSC 9739, Bethesda, MD 20852, USA.
Abstract:
Maintenance of genomic integrity is critical for adaptive survival in the face of endogenous and exogenous environmental stress. The loss of stability and fidelity in the genome caused by cancer and cancer treatment provides therapeutic opportunities to leverage the critical balance between DNA injury and repair. Blocking repair and pushing damaged DNA through the cell cycle using therapeutic inhibitors exemplify the 'pushmi-pullyu' effect of disrupted DNA repair. DNA repair inhibitors (DNARi) can be separated into five biofunctional categories: sensors, mediators, transducers, effectors, and collaborators that recognize DNA damage, propagate injury DNA messages, regulate cell cycle checkpoints, and alter the microenvironment. The result is cancer therapeutics that takes advantage of clinical synthetic lethality, resulting in selective tumor cell kill. Here, we review recent considerations related to DNA repair and new DNARi agents and organize those findings to address future directions and clinical opportunities.
Insights
Genomic integrity is vital for survival. DNA repair inhibitors (DNARi) exploit cancer
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Genomic integrity is crucial for survival against environmental stress.
- Cancer and its treatments disrupt DNA stability, creating therapeutic vulnerabilities.
- Targeting DNA repair pathways offers a promising strategy for cancer therapy.
Purpose of the Study:
- To review recent advancements in DNA repair inhibitors (DNARi).
- To categorize DNARi based on their biofunctional roles in DNA damage response.
- To explore future directions and clinical opportunities for DNARi in cancer treatment.
Main Methods:
- Literature review of recent research on DNA repair and DNARi.
- Classification of DNARi into five biofunctional categories: sensors, mediators, transducers, effectors, and collaborators.
- Analysis of the 'pushmi-pullyu' effect of disrupted DNA repair in cancer therapy.
Main Results:
- DNARi can be categorized by their roles in sensing DNA damage, signaling, checkpoint regulation, and microenvironment modulation.
- Disrupting DNA repair can lead to synthetic lethality, selectively killing cancer cells.
- New DNARi agents are emerging with potential for enhanced cancer treatment.
Conclusions:
- DNARi represent a significant therapeutic strategy by exploiting cancer's reliance on DNA repair mechanisms.
- Understanding the biofunctional categories of DNARi aids in developing targeted cancer therapies.
- Future research should focus on novel DNARi and their clinical translation for improved patient outcomes.
More Related Videos
Related Concept Videos
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Overview of DNA Repair
Chemically...

